Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$162,030,232
New position
Shares Held
821,571
first reported quarter
Ownership
0.053%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97.94649519031222.ToString("F0")%
Shared 0.ToString("F0")%
None 2.053504809687781.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. AZN ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
555,104 | $510,568,006 | |
| 2 | ABBV |
AbbVie Inc.
|
781,671 | $170,005,625 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
821,571 | $162,030,232 | |
| 4 | NVO |
Novo Nordisk A S
|
1,790,627 | $65,805,542 | |
| 5 | NVS |
Novartis AG
|
311,008 | $47,506,472 | |
| 6 | JNJ |
Johnson & Johnson
|
179,177 | $43,798,025 | |
| 7 | MRK |
Merck & Co., Inc.
|
157,451 | $18,939,780 | |
| 8 | GSK |
GSK plc
|
33,346 | $1,840,365 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,030,232 | 821,571 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||